During the past decade, Mútua de Terrassa conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 3 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mútua de Terrassa" #1 sponsor was "Grupo Cooperativo de Estudio y Tratamiento de las Leucemias Agudas y Mielodisplasias" with 3 trials, followed by "Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau" with 2 trials sponsored, "PETHEMA Foundation" with 2 trials sponsored, "AB Biotics, SA" with 1 trials sponsored and "Asociación para el Progreso de la Oncología en Málaga" with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mútua de Terrassa" #1 collaborator was "Consorci Sanitari de Terrassa" with 1 trials as a collaborator, "Fundació Ictus" with 1 trials as a collaborator, "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 1 trials as a collaborator, "General Electric" with 1 trials as a collaborator and "Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Mútua de Terrassa" are "HIV Infections" (3 trials), "Leukemia, Myelocytic, Acute" (2 trials), "Acute Lymphoblastic Leukemia" (1 trials), "Adult Respiratory Distress Syndrome" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Mútua de Terrassa" in a lesser frequency.

Most popular intervention types in "Mútua de Terrassa" are "Drug" (14 trials), "Other" (6 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ara-C" (3 trials), "Placebo" (3 trials), "G-CSF" (2 trials), "Prednisone" (2 trials) and "Allogeneic HLA-identical sibling transplantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mútua de Terrassa" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Mútua de Terrassa". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Mútua de Terrassa, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mútua de Terrassa, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 4 trials that are defined as “Not Applicable".